Cogent Biosciences, Inc.
COGT
$11.40
-$0.02-0.18%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -27.02% | -32.98% | -36.38% | -44.30% | -43.17% |
| Total Depreciation and Amortization | 12.52% | 21.27% | 8.20% | -42.39% | -34.93% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.82% | 35.21% | 35.08% | 120.36% | 106.00% |
| Change in Net Operating Assets | -21.87% | 1.35% | 33.10% | 2,460.68% | 923.25% |
| Cash from Operations | -33.09% | -35.26% | -37.65% | -30.89% | -28.36% |
| Capital Expenditure | 40.44% | 79.51% | 81.72% | 91.44% | 76.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 169.50% | 140.88% | 83.97% | -22.29% | -172.39% |
| Cash from Investing | 168.05% | 139.13% | 83.85% | -16.12% | -143.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -90.44% | 29.80% | 29.49% | 29.71% | 122.05% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 99.07% | 99.07% | -8.41% | -8.41% | 0.93% |
| Cash from Financing | -93.27% | 31.13% | 30.87% | 31.10% | 130.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -266.76% | 151.11% | 118.60% | -12.09% | 277.43% |